These discoveries indicate that besides overlapping therapeutic effect with familiar drugs by targeting MAOA/HTR1A/ABCG2 (Figure 5), herbal strategy may retain superiority on coronary artery atherosclerosis-related therapy through regulating disease symbols extensively, especially herbal strategy application with multiple herbs. The gene discussed is HTR1A; the disease is coronary atherosclerosis.